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CELL BIOLOGY

Inhibition of mitochondrial permeability transition
by deletion of the ANT family and CypD
Jason Karch1,2*†, Michael J. Bround1*, Hadi Khalil1, Michelle A. Sargent1, Nadina Latchman3,
Naohiro Terada4, Pablo M. Peixoto3, Jeffery D. Molkentin1,5†
The mitochondrial permeability transition pore (MPTP) has resisted molecular identification. The original model of
the MPTP that proposed the adenine nucleotide translocator (ANT) as the inner membrane pore-forming component
was challenged when mitochondria from Ant1/2 double null mouse liver still had MPTP activity. Because mice express
three Ant genes, we reinvestigated whether the ANTs comprise the MPTP. Liver mitochondria from Ant1, Ant2, and
Ant4 deficient mice were highly refractory to Ca2+-induced MPTP formation, and when also given cyclosporine A
(CsA), the MPTP was completely inhibited. Moreover, liver mitochondria from mice with quadruple deletion of Ant1,
Ant2, Ant4, and Ppif (cyclophilin D, target of CsA) lacked Ca2+-induced MPTP formation. Inner-membrane patch
clamping in mitochondria from Ant1, Ant2, and Ant4 triple null mouse embryonic fibroblasts showed a loss of MPTP
activity. Our findings suggest a model for the MPTP consisting of two distinct molecular components: The ANTs and
an unknown species requiring CypD.
INTRODUCTION

Mitochondrial permeability transition pore (MPTP) opening contributes to various pathologies involving necrotic cell death after
ischemic injuries or degenerative muscle and brain diseases (1–5).
The MPTP occurs within the inner mitochondrial membrane where
it is permeable to solutes of up to 1.5 kDa, and it opens in the presence
of high matrix Ca2+ and/or reactive oxygen species (6, 7). Although
numerous regulators of the MPTP have been identified, the molecular
pore-forming component of the MPTP remains uncertain (8, 9).
Halestrap and Davidson (10) first proposed that the adenine nucleotide translocator (ANT) family of genes could serve as the MPTP in
1990, which was consistent with the known effect of ANT ligands
and inhibitors on MPTP activity or the fact that reconstituted ANT
protein in lipid bilayers formed channel properties similar to the
MPTP (11–16). However, this model was challenged by the report
that mouse liver mitochondria lacking the genes Ant1 and Ant2 still
underwent mitochondrial permeability transition (MPT), albeit at
substantially higher levels of Ca2+ (17). Here, we investigated whether
the third Ant gene in mice, Ant4, compensates for the loss of Ant1
and Ant2 and whether mitochondria completely null for all ANT
isoforms would undergo MPT [humans contain four Ant genes
(Ant1 to Ant4), while mice lack Ant3] (18). More recently, a model
in which the mitochondrial F1FO ATP synthase (ATPase) serves as the
MPTP was proposed (19–21), although not without controversy as
some data dispute this model (22–24).
RESULTS

We first characterized the tissue distribution of all three ANT isoforms in the mouse by Western blotting from mitochondria lysates. In
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wild-type (WT) mice, ANT1 is the major isoform expressed in the
heart and skeletal muscle, while ANT2 is expressed in all tissues
examined besides the testis, the latter of which predominantly
expresses ANT4 (Fig. 1A). Of the three ANT isoforms, mouse liver
predominantly expresses ANT2 at baseline (Fig. 1A). In mice globally lacking either Ant1 or Ant4, the ANT2 isoform becomes up-
regulated to compensate for their loss (Fig. 1A). We observed that
ANT4 expression is induced in liver mitochondria from mice lacking
Ant1 and Ant2 (Fig. 1, B and C). This observation of compensation by
ANT4 when Ant1 and Ant2 were deleted from the liver likely explains
why Kokoszka and colleagues (17) failed to observe a more severe
loss of MPTP activity. The Ant2 gene was LoxP-targeted to permit
tissue-specific deletion, because full somatic Ant2−/− mice are embryonic lethal (25).
Here, we generated mice null for all ANT isoforms in the liver by
crossing total somatic Ant1−/−, Ant4−/− with Ant2-LoxP ( f l) mice with
an albumin promoter–driven Cre transgenic mouse line (Ant2fl/fl-Alb-Cre)
(17, 26). The loss of all ANT isoform expression in the liver was
confirmed by Western blot analysis on isolated liver mitochondria
(Fig. 1, D and E). In all liver-based experiments, Ant1−/− Ant4−/− Ant2fl/fl
mice were used as controls, because ANT2 is the overwhelming isoform expressed in liver (Fig. 1, A and D). This strategy allowed us to
directly compare littermates (Ant1−/− Ant4−/− Ant2fl/fl-Alb-Cre versus
Ant1−/− Ant4−/− Ant2fl/fl). Tetramethylrhodamine ethyl ester (TMRE)
staining showed comparable membrane potential that was sensitive to
carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) treatment
in mitochondria from Ant1−/− Ant4−/− Ant2fl/fl-Alb-Cre (Ant-triple-null)
livers and the ANT2-only expressing mice (Ant1−/− Ant4−/− Ant2fl/fl;
ANT2-only) (Fig. 1F). Hematoxylin and eosin (H&E)–stained histological liver sections and transmission electron microscopy also showed
no overt pathology in Ant-triple-null versus ANT2-only expressing mice (fig. S1A). In an unexpected deviation from previous work
(17), Ant-triple-null mitochondria from liver showed no difference in
adenosine diphosphate (ADP)–stimulated and maximum oxygen consumption rates and no decrease in ATP levels when compared with
ANT2-only controls, suggesting that ANT function is somehow compensated for in these mitochondria, presumably by another Slc25a family
member (figs. S1B and S2, A to C).
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Fig. 1. Tissue-specific expression and compensation of the ANT family. (A) Western blots of isolated mitochondria from various mouse tissues for ANT1, ANT2, ANT4,
and a loading control for electron transport chain complex V (ComV). ANT2 protein is up-regulated in all five tissues analyzed to compensate for the loss of the Ant1 gene.
ANT2 is up-regulated in testis in response to loss of the Ant4 gene. These results are representative of three independent experiments. (B) Western blots for ANT2 and
ANT4 from isolated liver mitochondria from the indicated gene-targeted mice showing that ANT4 is induced for the first time in the absence of the Ant1 and Ant2 genes.
A loading control for ComV is shown. These results are representative of three independent experiments. (C) Quantification of ANT4 expression normalized to ComV
expression, as in (B) (n = 3; *P ≤ 0.05). (D) Western blots of ANT1, ANT2, ANT4, and a loading control for ComV, performed using extracts of isolated liver mitochondria from
Ant1−/− Ant4−/− Ant2fl/fl (ANT2-only) and Ant1−/− Ant4−/− Ant2fl/fl-Alb-Cre (Ant-triple-null) mice. Data are representative of three independent experiments. (E) Quantification
of ANT2 expression normalized to ComV expression, as in (D) (n = 4; *P ≤ 0.05). (F) Representative fluorescence-activated cell sorting analysis of TMRE-stained mouse liver
mitochondria isolated from Ant1−/− Ant4−/− Ant2fl/fl versus Ant1−/− Ant4−/− Ant2fl/fl-Alb-Cre mice. The TMRE fluorescence threshold is shown in the bottom of the panel versus
when no fluorescence signal is detected above background. FCCP is a potent uncoupler of mitochondrial respiration, which is provided to depolarize mitochondria. Results
are representative of three independent experiments.

To investigate the status of MPTP activity, we simultaneously
used the two most common MPTP assays in isolated mitochon
dria: that of Ca2+ retention capacity (CRC) using stepwise 40 M Ca2+
additions over time and that of absorbance-based assessment of
mitochondrial swelling. Mitochondria from WT mouse liver took
up three stepwise Ca2+ additions before opening and releasing their
Ca2+ into the solution (Fig. 2A). This Ca2+-induced MPTP opening
caused immediate mitochondria swelling in the solution, indicated
by a decrease in light absorbance (Fig. 2B). Consistent with previous
results (17), loss of ANT1 and ANT2 desensitized Ca2+-induced
MPTP opening to a similar extent as WT mitochondria treated
with cyclosporine A (CsA) (27, 28), which is an inhibitor of the
MPTP regulator cyclophilin D (CypD) (Fig. 2, A and B). Mitochondria
lacking all isoforms of the ANT family are further desensitized to
Ca2+-induced MPTP opening; however, the MPTP still opened
with very high levels of Ca 2+ (Fig. 2, A and B, and fig. S1C),
confirming that the ANT family is still dispensable for MPTP
opening in the liver. In contrast, Ant-triple-null mitochondria that
were also treated with CsA showed no mitoc hondrial swelling
despite taking up Ca2+ to the physical limits of the assay (4.8 mM Ca2+)
(Fig. 2, A and B, and fig. S1C). Ant-triple-null mitochondria treated
with CsA swelled when treated with the nonspecific permeabilizing
agent alamethicin, demonstrating that Ant-triple-null mitochon
dria were otherwise intact and capable of swelling (Fig. 2B,
arrowhead).
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We observed a similar synergistic effect in the reciprocal experiment when Ppif−/− mitochondria lacking CypD were treated with
ADP, a known desensitizer of the MPTP and ligand for ANT
(Fig. 2, C and D, and fig. S1C). Together, these data reveal that MPTP
formation requires at least one ANT family member or CypD to occur.
These studies further suggest that there may be at least two separate
pores that comprise total MPTP activity in liver: one pore consisting
of the ANT family that can escape CypD regulation and another
that is dependent on CypD to open.
To further address the data obtained in purified mitochondria
with CsA in Ant-triple-null mice, we independently generated
quadruple-null mice for Ant1, Ant2, Ant4, and Ppif. We compared
the CRC and swelling measurements in liver mitochondria
from these quadruple-null mice versus ANT2-only control mice
(Fig. 3, A to C). While ANT2-only mitochondria took up a limited
number of 40 M Ca2+ boluses before pore opening and swelling,
the quadruple-null never underwent swelling and took up Ca2+
boluses until the Ca2+ sensing potential of the assay was saturated
(Fig. 3, A and B). Electron microscopy showed that liver mitochondria from ANT2-only control mice, Ant-triple-null mice, and
Ppif−/− mice had morphologically normal mitochondria at baseline
in Ca2+-free buffer, but after the addition of 800 M Ca2+, all showed
profound swelling (Fig. 3C). Conversely, mitochondria from Ant1−/−
Ant4−/− Ppif−/− Ant2fl/fl-Alb-Cre quadruple-null livers failed to show
swelling (Fig. 3C, red arrowheads), despite also using half the amount
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Fig. 2. Loss of the ANT family or CypD desensitizes the MPTP, while Ant family deletion with CsA completely inhibits MPTP opening. (A) Ca2+ retention capacity
(CRC) assay with Calcium Green-5N fluorescence indicator in the buffer was performed using purified liver mitochondria isolated from wild-type (WT), Ant1−/− Ant2fl/fl-Alb-Cre, or
Ant1−/− Ant4−/− Ant2fl/fl-Alb-Cre mice treated with or without 5 M cyclosporine A (CsA). Two milligrams of mitochondria were used in each assay, and 40 M pulses of CaCl2 were
continually given (represented by each peak in fluorescence in the traces) until mitochondria either underwent MPTP or displayed saturated Ca2+ uptake. The arrowhead shows 40 M
alamethicin addition, a membrane-permeabilizing agent. (B) Simultaneous with the CRC assay shown in (A), light absorbance was recorded during the course of Ca2+ additions
to measure mitochondrial swelling represented by a decrease in absorbance. The results shown are representative traces from at least three independent assays. AU, arbitrary units.
(C) CRC assay using conditions similar to those of (A) performed on liver mitochondria isolated from WT or Ppif−/− mice treated with or without 50 M ADP. (D) Absorbance-based
mitochondria swelling was simultaneously measured in the CRC assay samples shown in (C). The results shown are representative traces from at least three independent assays.
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of mitochondria (1 mg versus 2 mg) to correct for baseline absorbance
differences (fig. S3A). Similar to the Ant-triple-null mitochondria,
Ant1−/− Ant4−/− Ppif−/− Ant2fl/fl-Alb-Cre quadruple-null mitochondria
displayed no alteration in morphology or stimulated oxygen consumption under energized conditions (fig. S3, B and C).
To extend these findings to another model system, we also generated
mouse embryonic fibroblasts (MEFs) lacking all ANT isoforms (Fig. 4A).
In contrast to the liver mitochondria, mitochondria isolated from
Ant1−/− Ant4−/− Ant2fl/fl-(AdCre) MEFs (Ant-triple-null) did not show
compensation in their ability to transport ATP/ADP so that these mitochondria had almost no respiratory capacity and reduced ATP
levels with increased ADP (Fig. 4B and fig. S2, D to F). The relative
increase in ADP may contribute to MPTP desensitization in these mitochondria from Ant-triple-null MEFs. To explore whether Ant-triple-
null MEFs depend on glycolysis to generate ATP, we grew them in
glucose-free, galactose-containing culture media, making glycolysis
an ATP futile process. Under these conditions, the Ant-triple-null MEFs
died within 24 hours, whereas the control MEFs were unaffected
(Fig. 4D). We observed similar cell death in Ant-triple-null MEFs
within 12 hours of treatment with 40 mM 2-deoxygluose, a potent
inhibitor of glycolysis. Despite reduced mitochondrial respiration,
Ant-triple-null MEFs were still capable of generating mitochondrial
Karch et al., Sci. Adv. 2019; 5 : eaaw4597
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membrane potential () in culture, as measured by TMRE fluorescence
(Fig. 4C), presumably from pyruvate and reducing equivalents
generated from glycolysis.
We also assessed MPTP activity by patch clamping of the inner
mitochondrial membrane to identify its known opening and conductance
properties. Mitoplasts isolated from WT and ANT2-only MEFs (Ant1−/−
Ant4−/− Ant2fl/fl) showed channel opening and conductance levels
consistent with the MPTP, and importantly, ADP, an MPTP suppressor,
inhibited pore opening events (Fig. 4, E and F). Patching of mitoplasts
from Ant-triple-null MEFs showed a much lower prevalence of large
pores, and all such rare pores were unresponsive to ADP, suggesting
that no MPTP-like channels were present without ANT (Fig. 4, E
and G). These results suggest that the ANT family is the primary
inner-membrane channel-forming component of the MPTP in MEFs.
DISCUSSION

In summary, we have genetically abolished MPT by deletion of the
ANT family and CypD in liver mitochondria, validating the original
model proposed for this phenomenon. However, in liver mitochondria,
our data support a “multi-pore model” where the MPTP is composed of at least two distinct molecular components, one of which
4 of 7
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is ANT and the other depends on CypD (fig. S4). In these mitochon
dria, the ANT-dependent MPT activity, while likely regulated
by CypD, is able to activate independently of CypD in response to
higher mitochondrial matrix Ca2+ levels. Meanwhile, the second,
unknown MPTP component requires the presence of CypD and cannot
activate in its absence. The possibility that the MPTP is composed
of at least two pore-forming components may explain why identifying
its gene products has been controversial. However, it is also possible
that CypD and the ANTs activate a still unknown common pore in
a “dual regulator model.” In this situation, the MPTP is regulated by
ANTs and CypD that can function independently. Our data suggest
that this hypothetical common pore requires at least CypD or the
ANTs to activate and that both regulators must be disrupted to
silence the MPTP. Despite this possibility, MEFs lacking all three
Ant genes completely lack MPTP activity, suggesting that ANT
directly constitutes the fundamental unit of pore activity in select cell
types. In moving forward, it will be important to identify the additional unknown CypD-dependent component of the MPTP in the
liver. For example, other Slc25a family members, such as the Slc25a3
(mitochondrial phosphate carrier), or the mitochondrial F1FO ATPase
could fulfill such a role (19–21, 29, 30).
MATERIALS AND METHODS

Animal models
Ant1−/− (Slc25a4) Ant2-LoxP (fl) (Slc25a5) mice and Ant4−/− (Slc25a31)
mice were described previously (16, 17). To generate liver-specific
deletion Ant2fl/fl in mice, we crossed in an albumin-Cre transgenic
line (the Jackson Laboratory, 003574). To delete the CypD gene
product, we used mice lacking a functional Ppif gene (27). Ppif−/− mice
were crossed to contain the Ant1−/− Ant4−/− and Ant2fl/fl-Alb-Cre alleles
to generate quadruple gene-deleted mice. Ant-triple-null liver was
generated in Ant1−/− Ant4−/− Ant2fl/fl-Alb-Cre mice, which were compared with Ant1−/− Ant4−/− and Ant2fl/fl littermates that lacked the
albumin-Cre transgene, and hence, these mice only expressed ANT2
(ANT2-only), which is the predominant ANT family member normally
expressed in liver. However, liver mitochondria from ANT2-only
mice showed identical mitochondrial CRC and Ca2+-induced swelling
to fully WT mitochondria. Moreover, mitochondrial ultrastructure
in liver from neither Ppif −/− nor Ant1 −/− Ant4 −/− Ant2 fl/fl-Alb-Cre
mice showed alterations compared with WT mitochondria (see fig. S3C).
All experimental procedures with animals were approved by the
Institutional Animal Care and Use Committee of Cincinnati Children’s
Medical Center, protocols IACUC 2015-0047 and 2016-0069. We
have complied with the relevant ethical considerations for animal
usage overseen by this committee. The number of mice used in this
study reflects the minimum number needed to achieve statistical
significance based on experience and previous power analysis.
Blinding was performed for some experimental procedures with
mice, although blinding was not possible in every instance. Both
sexes of mice were used in equal ratios.
Cell culture models
MEFs were generated by harvesting Ant1−/− Ant2fl/fl Ant4−/− embryonic
day 10.5 embryos. After the removal of the internal organs and the
head, the remainder of the bodies were passed through a 25-gauge
needle and plated on 10-cm2 tissue culture dishes and cultured in
Dulbecco’s modified Eagle’s medium (DMEM) (Thermo Fisher
Scientific) containing 10% bovine growth serum (BGS, Thermo
Karch et al., Sci. Adv. 2019; 5 : eaaw4597
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Fisher Scientific), penicillin-streptomycin (Thermo Fisher Scientific),
and nonessential amino acids (Invitrogen). After two passages, the
MEFs were subjected to simian virus 40 (SV40) large T antigen
immortalization by infecting with an SV40 T antigen–expressing
lentivirus (Addgene, plasmid 22298, pLenti CMV/TO SV40 small +
large T). Once immortalization was achieved, cells were treated with
an adenovirus expressing both green fluorescent protein (GFP) and
Cre recombinase (AdCre) for Ant2 gene deletion. Before infection,
these MEFs were switched to “Rho 0” medium, which was the standard DMEM described above supplemented with uridine (50 g/ml;
Sigma-Aldrich) and 1 mM sodium pyruvate (Thermo Fisher Scientific). After infection, MEFs were subjected to fluorescent-activated
cell sorting to isolate individual GFP-positive cells that had AdCre
virus infection, which established clonal Ant-triple-null MEFs. Validation of the loss of ANT2 protein was determined by Western blot
analysis. After cell selection, we were able to culture Ant-deleted
MEF lines in high-glucose DMEM (4.5 g/liter glucose; Thermo
Fisher Scientific) supplemented with 10% BGS (Thermo Fisher Scientific) and nonessential amino acids (Invitrogen). To determine if
the Ant-triple-null MEFs relied on mitochondria-produced ATP for
survival, we cultured the MEFs in glucose-free media (Thermo
Fisher Scientific) with the addition of galactose (4500 mg/ml; Sigma-
Aldrich), which caused their death within 24 hours, as measured
with the Muse Cell Analyzer (MilliporeSigma) and the Muse Count
& Viability Assay Kit (MilliporeSigma). To further test ANT MEF
reliance on glycolysis, we treated cells cultured in Rho 0 media
containing 40 mM 2-deoxyglucose (Sigma-Aldrich). Cells were
visually inspected 12 hours later for survival.
Mitochondrial isolation
The brain, heart, muscle, liver, testis, and MEF mitochondria were
isolated in MS-EGTA buffer [225 mM mannitol, 75 mM sucrose, 5 mM
Hepes, and 1 mM EGTA (pH 7.4); Sigma-Aldrich]. The various tissues
were minced into 2 mm by 2 mm pieces and then homogenized using
a glass and Teflon tissue homogenizer (8 to 15 strokes, depending
on the tissue) on ice and in MS-EGTA buffer. Tissue homogenates
were then subjected to a 2500g centrifugation for 5 min (1×), and
the supernatants were then centrifuged at 11,500g for 10 min. The
MEFs were grown to confluency on four Nunc Bioassay Dishes
(Sigma-Aldrich) and then harvested and pelleted in MS-EGTA buffer.
The cells were then suspended in 7 ml of buffer and homogenized
with a glass and Teflon tissue homogenizer (10 strokes). MEF homogenates were then subjected to a 2500g centrifugation for 5 min (2×),
and the supernatants were then centrifuged at 11,500g for 10 min.
In both situations, pellets were then washed and centrifuged
2× (11,500g) and then snap-frozen or suspended in KCl buffer [125 mM
KCl, 20 mM Hepes, 2 mM MgCl 2, 2 mM KH2PO4, and 40 M
EGTA (pH 7.2); Sigma-Aldrich].
CRC and mitochondrial swelling assays
The CRC assay and the mitochondrial swelling assay were performed
simultaneously using a dual-detector (one to measure fluorescence
and the other to measure absorbance), single-cuvette–based fluorimetric system (Horiba Scientific). Depending on the experiment,
1 or 2 mg of isolated mitochondria was loaded into the cuvette along
with 250 nM Calcium Green-5N (Invitrogen), 7 mM pyruvate
(Sigma-Aldrich), and 1 mM malate (Sigma-Aldrich) and brought
up to 1 ml using KCl buffer. Mitochondria were then pulsed with
sequential additions of CaCl2 (40 or 800 M) until MPTP opening
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occurred or until the mitochondria reached a CaCl2 saturation point
and could no longer take up more Ca2+. In certain situations where
the experimental mitochondria did not undergo a swelling event
following CaCl2 additions, they would be subjected to a membrane-
permeabilizing agent, 40 M alamethicin (Santa Cruz Biotechnology),
to show that they still had swelling capacity and were not otherwise
compromised.
TMRE assay
MEFs were plated on glass-bottom tissue culture dishes and loaded
with 50 nM TMRE (Thermo Fisher Scientific) for 10 min. Following
loading, cells were washed twice with Hanks’ balanced salt solution
(Thermo Fisher Scientific) and immediately visualized using a Nikon
A1 inverted confocal microscope (Nikon) (488 nm excitation/575 nm
emission). Isolated liver mitochondria suspended in KCl buffer
were loaded with 50 nM TMRE for 10 min and then centrifuged
and washed with fresh KCl buffer. The mitochondria were then immediately analyzed by flow cytometry (488 nm excitation/575 nm
emission). TMRE positivity was confirmed by treating loaded mitochon
dria with 5 M FCCP (Abcam) and recording a large negative shift
in the entire mitochondrial population.
Western blotting
All Western blots were performed using isolated mitochondrial
lysates. Following mitochondrial isolations, the mitochondrial pellets
were suspended in radioimmunoprecipitation buffer containing
protease inhibitor cocktails (Roche). The samples were then sonicated, and the insoluble fractions were discarded following centrifugation. SDS sample buffer was added to the lysates, and
samples were boiled for 5 min. The samples were then loaded onto
10 to 15% acrylamide gels and then transferred onto polyvinylidene
fluoride transfer membranes (MilliporeSigma). The following
primary antibodies were used: Slc25a4 (ANT1) (Signalway Antibody;
32484; 1:500), Slc25a5 (ANT2) (Cell Signaling Technology; 14671;
1:500), ANT4 polyclonal antibody (Signalway Antibody; 40596-1;
1:500), and Total OXPHOS rodent WB antibody cocktail (that
contained antibodies to complexes 1 to 5, ComII, or ComV as labeled
in Western blots) (Abcam; ab110413; 1:15,000).
Metabolic analysis
Oxygen consumption rate was determined using an XF Extracellular
Flux Analyzer (Agilent Technologies). MEFs were plated in XF24
microplates (Agilent Technologies) and grown to confluency in Rho
0 media (as described above), and switched to an assay medium composed of Seahorse XF base medium (Agilent Technologies) supplemented with 10 mM glucose (Agilent Technologies), 1 mM pyruvate
(Agilent Technologies), and 2 mM l-glutamine (Agilent Technologies),
and subjected to the Mito Stress Test Kit (Agilent Technologies)
using the standard protocol provided. Briefly, after basal respiration
was measured, the MEFs were treated sequentially with 2 M oligomycin,
2 M FCCP, and 0.5 M rotenone. Isolated liver mitochondria (300 g)
were loaded onto XF24 cell culture microplates in KCl buffer containing 7 mM pyruvate and 1 mM malate and subjected to the Mito
Stress Test Kit using the standard protocol provided. Briefly, after
basal respiration was measured, the mitochondria were treated
sequentially with 10 mM ADP, 2 M oligomycin, 5 M FCCP, and
0.5 M rotenone. To interrogate ADP uptake, 200 g of isolated
liver or MEF mitochondria was loaded onto XF24 cell culture
microplates in KCl buffer containing 7 mM pyruvate and 1 mM
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malate and treated sequentially with ascending concentrations of
ADP (0.5, 2, and 2.5 mM) followed by 0.5 M rotenone.
Adenine nucleotide concentrations were measured using chemical assay
kits. The Abcam ATP Assay Kit (Abcam) was used to measure mitochondrial ATP levels. Either 2 mg of previously frozen, isolated liver mitochondria or 1 mg of previously frozen, isolated MEF mitochondria was
suspended in 100 l of KCl buffer and diluted with 400 l of ATP assay
buffer. Either 40 g of liver mitochondria or 20 g of MEF mitochondria
was added to each assay, and ATP levels were measured according to
the fluorometric assay protocol. Cell Technology Fluoro ADPTM: fluorescent Cellular and Tissue ADP Detection Kit (Cell Technology) was
used to measure mitochondrial ADP levels. Either 2 mg of previously
frozen, isolated liver mitochondria or 1 mg of previously frozen, isolated
MEF mitochondria was suspended in 100 l of KCl buffer and diluted
with 200 l of substrate buffer and sonicated for 3 min. One hundred ten micrograms of liver mitochondria or 55 g of MEF mitochondria was added to each assay, and ADP levels were measured
according to the Fluoro ADP Assay protocol (Cell Technology).
Histological analyses
Histological analyses of the H&E-stained slides of 7-m liver sections
were performed using an upright microscope 4× objective. Electron
microscopy was performed on livers and isolated mitochondria
from livers. Before fixation, the isolated mitochondria were subjected
to the mitochondrial swelling assay with or without CaCl2 (two
pulses of 400 M CaCl2 to achieve 800 M). Samples were then
fixed in glutaraldehyde and cacodylate, embedded in epoxy resin,
and sectioned. Sections were counterstained with uranyl acetate
and lead citrate. Images were taken at 5000× and 3500×.
Patch-clamping techniques
MEFs at 80% confluency were harvested, and mitochondria were
isolated as previously described (31). Mitoplasts were spontaneously
formed by diluting isolated mitochondria 100-fold in patching media
(see below) for 10 min, which caused controlled swelling and rupture of the outer membrane. Mitoplasts can be easily distinguished
from intact mitochondria, as they appear as larger and more translucent ring-like structures studded by a curled outer membrane.
Inner-membrane patches were excised from mitoplasts after formation of a seal using micropipettes with approximately 0.3-m tips
and resistances of 10 to 30 megohms at room temperature. Patching medium was 150 mM KCl, 5 mM Hepes, 1.25 mM CaCl2, and 1 mM
EGTA (pH 7.4). Voltages were clamped with a Dagan 1200 amplifier
and reported as pipette potentials. Permeability was typically determined from stable current levels and/or total amplitude histograms
of 30 s of data at +20 mV. pCLAMP version 8 (Axon Instruments)
and WinEDR v2.3.3 (Strathclyde Electrophysiology Software) were
used for current analysis as previously described (32). Sample rate
was 5 kHz with 1- to 2-kHz filtration. To determine whether the
large conductance activity was due to the MPTP through the ANT
family, patching medium containing 1 mM ADP/MgCl 2 was
administered by bath perfusion.
SUPPLEMENTARY MATERIALS

Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/8/eaaw4597/DC1
Fig. S1. Loss of Ant1/2/4 genes in the liver does not compromise mitochondrial energetics or
cause tissue pathology.
Fig. S2. Adenine nucleotide levels and transport in liver and MEF mitochondria lacking ANT
proteins.
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Fig. S3. Mitochondria from quadruple null mice fail to undergo Ca2+-induced MPTP, although
no defects in energetics or mitochondrial ultrastructure were observed.
Fig. S4. Model of the MPTP.
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